SOLICITATION NOTICE
V -- Dismantling and Reinstallation of BSL2 Microcell System
- Notice Date
- 11/17/2010
- Notice Type
- Presolicitation
- NAICS
- 339999
— All Other Miscellaneous Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-PB-(HG)-2011-024-DLM
- Archive Date
- 12/5/2010
- Point of Contact
- Dorothy Maxwell, Phone: 301-435-0352
- E-Mail Address
-
maxwelld@mail.nih.gov
(maxwelld@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR A PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. The National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisition (OA) intends to negotiate and award a purchase order on a noncompetitive sole source basis to HighRes Biosolutions Inc, 299 Washington Street, Woburn, Massachusetts 01801-2795 to procure the service to disassemble, relocate and modify an existing HighRes Biosystem Robot. The sole source determination is based on the fact that National Institute of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency conducting, supporting and making medical discoveries that improve people’s health and save lives. The National Human Genome Research Institute (NHGRI), NIH Chemical Genomics Center (NCGC), Robotics Center is severely limited in available space and to make room for the new robotics system the existing HighRes Biosystem Robot needs to be relocated. The relocation of the system requires the services of the manufacturer of the system to ensure the relocation is accomplished with no damage to the robot and that the system performs to specifications after the move. High Resolution Engineering (HRE) will dismantle, relocate and then install the BSL2 Microcell system into a temporary location within the existing Kalypsys High Throughput Screening Robotic area. By relocating this existing HRE System, NCGC will be able to obtain additional custom solutions for the ongoing needs of our screening facility here at NCGC for compound storage and replication. HRE has extensive in-house experience designing and fabricating, and relocating these unique and extremely sensitive proprietary systems that have several unique robotic configurations within the BSL2 controlled environment enclosures. Flexibility and customization are key elements of our existing robotic system that was manufactured by HRE. Since so many of our ongoing assay screening projects are unique and dependent on the use of this system, having the flexibility to custom fit the screening needs into this area will allow us to increase productivity while maintaining compound integrity. Many of the proposed features will be essential to the increased productivity, but maintaining the integrity of the custom docking stations that will allow top-feeding incubators and carousels to be moved to and from the cell in a matter of seconds will be essential to the changing needs of our assay development. This proposed move and configuration will enhance the screening capabilities of NCGC robotic center immensely by providing the clinical grade clean room environment that will continue to allow us to provide screening on assays currently not available on our existing robot. The HRE Robot, used for BioSafety Level 2 screening assays, needs to be relocated in the Kalypsys room to allow space for an additional Aspect robotic system. The BSL2 MicroCell can only be moved by HighRes Biosolutions due to the software configuration with robotic arms and ancillary dispensers, sealers, centrifuges, and incubators that are working inside the custom lateral flow enclosure. The existing system features Trespa surfaces and epoxy-coated robots to avoid bioloading. This proposed system relocation by HRE will maintain the integrated sealed incubators and microplate storage that move to and from the system via carts and mate with MicroDock docking stations. In addition, this relocation will maintain the custom process to store solid and liquid waste in a sealed environment from which the waste can be removed by an operator. The relocation must maintain the innovative docking station integrity that offers us the modularity and flexibility we need to perform our complex assays, and allowing us to easily change system configurations when new technologies are available. Only one responsible source and no other supplies or services will satisfy agency requirements. Industry Classification (NAICS) Code is 339999, All Other Miscellaneous General Purpose Machinery Manufacturing, with business size standard 500 Employees. The acquisition is being conducted under FAR Part 13, simplified acquisition procedures, therefore the requirements of FAR Part 6 B Competitive Requirements are not applicable (FAR Part 6.001) and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-46 (October 29, 2010). This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this synopsis, by November 20, 2010, 7:30 a.m. Eastern Standard Time. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct future competitive procurement. Inquires to this announcement, referencing synopsis number NHLBI-PB-(HG)-2011-024-DLM, may be submitted to the National Heart, Lung and Blood Institute, Office of Acquisition, Procurement Branch, 6701 Rockledge Drive, Suite 6149, Bethesda, Maryland 20892-7902, Attention: Dorothy Maxwell. Response may be submitted electronically to maxwelld@mail.nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/NHLBI-PB-(HG)-2011-024-DLM/listing.html)
- Place of Performance
- Address: NIH, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN02328982-W 20101119/101117234240-4e064f67a350693d5b4ae72708fc9bf4 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |